Form 4: Nevro Corp Director Michael F. DeMane Reports Changes in Beneficial Ownership

Director Michael F. DeMane reports acquisition and disposal of Nevro Corp common stock on December 31, 2024.

Summary

• On December 31, 2024, Michael F. DeMane, a director of Nevro Corp, reported changes in beneficial ownership of the company's common stock.
• DeMane acquired 7,056 shares of common stock at $0, representing fully vested restricted stock received in lieu of cash retainer fees.
• Following the transaction, DeMane directly owns 61,863 shares, which includes 19,169 restricted stock units.
• DeMane also indirectly owns 164,344 shares through the Michael F. DeMane 2012 Irrevocable Trust, 219,145 shares through the Michael F. DeMane 2017 Family SLAT Trust, and 58,266 shares through the Michael F. DeMane Revocable Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating stock transactions by a director. The acquisition of shares could be seen as slightly positive, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

This filing is a routine disclosure related to insider trading regulations and provides transparency into the stock ownership of Nevro Corp's director.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the stock ownership of a key company director.

Key Dates